Marsicano G: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{EAGLE | |||
|COST= Participant | |||
}} | |||
{{Person | {{Person | ||
|lastname=Marsicano | |lastname=Marsicano |
Revision as of 09:24, 2 May 2016
News and Events | Working Groups | Short-Term Scientific Missions | Management Committee | Members |
COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping
Marsicano G
MitoPedia topics: EAGLE
COST: Participant
Name | Marsicano Giovanni, DVM, PhD |
---|---|
Institution | Giovanni Marsicano DVM, PhD
NeuroCentre Magendie U862 INSERM UniversitΓ© Bordeaux 2 Group "Endocannabinoids and Neuroadaptation" |
Address | 146, rue LΓ©o Saignat, 33077 |
City | Bordeaux |
State/Province | |
Country | France |
[email protected] | |
Weblink | |
O2k-Network Lab |
Labels:
Publications
Published | Reference | |
---|---|---|
Haney 2023 Nat Med | 2023 | Haney M, VallΓ©e M, Fabre S, Collins Reed S, Zanese M, Campistron G, Arout CA, Foltin RW, Cooper ZD, Kearney-Ramos T, Metna M, Justinova Z, Schindler C, Hebert-Chatelain E, Bellocchio L, Cathala A, Bari A, Serrat R, Finlay DB, Caraci F, Redon B, MartΓn-GarcΓa E, Busquets-Garcia A, Matias I, Levin FR, Felpin FX, Simon N, Cota D, Spampinato U, Maldonado R, Shaham Y, Glass M, Thomsen LL, Mengel H, Marsicano G, Monlezun S, Revest JM, Piazza PV (2023) Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials. https://doi.org/10.1038/s41591-023-02381-w |